Tuberculosis vaccine development; from mouse to man
- 31 May 2005
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 7 (5-6) , 922-931
- https://doi.org/10.1016/j.micinf.2005.03.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis -Infected Guinea PigsInfection and Immunity, 2004
- Priming by DNA Immunization Augments Protective Efficacy ofMycobacterium bovisBacille Calmette-Guerin against TuberculosisInfection and Immunity, 2001
- Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6Infection and Immunity, 2001
- Boosting Vaccine for TuberculosisInfection and Immunity, 2001
- Enhanced Immunogenicity of CD4+T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine TuberculosisInfection and Immunity, 2001
- Mucosal Bacille Calmette-Guérin Vaccination of Humans Inhibits Delayed-Type Hypersensitivity to Purified Protein Derivative but Induces Mycobacteria-Specific Interferon-γ ResponsesClinical Infectious Diseases, 2000
- In Vitro Measurement of Protective Mycobacterial Immunity: Antigen-Specific Expansion of T Cells Capable of Inhibiting Intracellular Growth of Bacille Calmette-GuérinClinical Infectious Diseases, 2000
- Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human Cd4+ T CellsThe Journal of Experimental Medicine, 2000
- ESAT-6 Subunit Vaccination againstMycobacterium tuberculosisInfection and Immunity, 2000
- The BCG Story: Lessons from the Past and Implications for the FutureClinical Infectious Diseases, 1989